These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36480765)

  • 41. Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.
    Lo Re V; Teal V; Localio AR; Amorosa VK; Kaplan DE; Gross R
    Ann Intern Med; 2011 Sep; 155(6):353-60. PubMed ID: 21930852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report.
    Said A; Weiss M; Varhelyi A; Farago R; Ballweg C; Rice J; Agarwal P; Fernandez L; Foley D
    Transpl Infect Dis; 2021 Apr; 23(2):e13466. PubMed ID: 32931616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.
    Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G
    J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
    Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ
    J Viral Hepat; 2019 Aug; 26(8):969-979. PubMed ID: 30980785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of proton pump inhibitors on sustained virologic response in veterans treated with sofosbuvir/velpatasvir for chronic hepatitis C virus: A retrospective cohort study.
    Rumph DM; Straley CM; Kolberg JL; Jacob DA
    Pharmacotherapy; 2022 May; 42(5):397-404. PubMed ID: 35396730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infection.
    Rentsch CT; Cartwright EJ; Gandhi NR; Brown ST; Rodriguez-Barradas MC; Goetz MB; Marconi VC; Gibert CL; Re VL; Fiellin DA; Justice AC; Tate JP
    Ann Epidemiol; 2018 Nov; 28(11):808-811. PubMed ID: 30195616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Impact of a Sustained Virologic Response to Hepatitis C Virus Treatment on Liver Stiffness in the Puerto Rico Veterans Attending Liver Clinics in the Veterans Affairs Caribbean Healthcare System.
    Rabell-Bernal A; López-Valle R; Morales-Santiago A; Toro DH
    P R Health Sci J; 2022 Sep; 41(3):123-127. PubMed ID: 36018739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Race affects SVR12 in a large and ethnically diverse hepatitis C-infected patient population following treatment with direct-acting antivirals: Analysis of a single-center Department of Veterans Affairs cohort.
    Benhammou JN; Dong TS; May FP; Kawamoto J; Dixit R; Jackson S; Dixit V; Bhattacharya D; Han SB; Pisegna JR
    Pharmacol Res Perspect; 2018 Apr; 6(2):e00379. PubMed ID: 29484189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of stigma and trauma in hepatitis C virus treatment in veterans: Applying the common-sense model.
    Garvey CM; Jones R
    Public Health Nurs; 2019 Nov; 36(6):829-835. PubMed ID: 31583773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of Treatment Eligibility in Veterans With Hepatitis C Viral Infection.
    Taylor J; Carr-Lopez S; Robinson A; Malmstrom R; Duncan K; Maniar A; Re ACD; Carmichael JM
    Clin Ther; 2017 Jan; 39(1):130-137. PubMed ID: 27989619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES).
    Butt AA; Yan P; Aslam S; Shaikh OS; Abou-Samra AB
    Clin Infect Dis; 2020 Mar; 70(6):1153-1160. PubMed ID: 30977808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma.
    Beste LA; Green PK; Berry K; Kogut MJ; Allison SK; Ioannou GN
    J Hepatol; 2017 Jul; 67(1):32-39. PubMed ID: 28267622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stability and Validity of the Veterans Health Administration's Traumatic Brain Injury Clinical Reminder Screen.
    Vanderploeg RD; Belanger HG
    J Head Trauma Rehabil; 2015; 30(5):E29-39. PubMed ID: 25310297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rate and predictors of treatment prescription for hepatitis C.
    Butt AA; Justice AC; Skanderson M; Rigsby MO; Good CB; Kwoh CK
    Gut; 2007 Mar; 56(3):385-9. PubMed ID: 17005764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores.
    Ioannou GN; Beste LA; Green PK; Singal AG; Tapper EB; Waljee AK; Sterling RK; Feld JJ; Kaplan DE; Taddei TH; Berry K
    Gastroenterology; 2019 Nov; 157(5):1264-1278.e4. PubMed ID: 31356807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. National Hepatitis C Surveillance Day in the Veterans Health Administration of the Department of Veterans Affairs.
    Roselle GA; Danko LH; Kralovic SM; Simbartl LA; Kizer KW
    Mil Med; 2002 Sep; 167(9):756-9. PubMed ID: 12363168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained virologic response with 6 weeks or less of direct-acting antiviral therapy for chronic hepatitis C: Experience at a veterans affairs healthcare system.
    Joshi P; Atherton A
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2173-2178. PubMed ID: 31062412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of Hepatitis C Virus Infection in the Veteran Population Undergoing Total Joint Arthroplasty: An Update.
    Shapiro CBH; Cheung RC; Giori NJ
    J Arthroplasty; 2021 Feb; 36(2):467-470. PubMed ID: 32900563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retreatment of hepatitis C with consensus interferon and ribavirin after nonresponse or relapse to pegylated interferon and ribavirin: a national VA clinical practice study.
    Yee HS; Currie SL; Tortorice K; Cozen M; Shen H; Chapman S; Cunningham F; Monto A
    Dig Dis Sci; 2011 Aug; 56(8):2439-48. PubMed ID: 21633833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey.
    El-Serag HB; Alsarraj A; Richardson P; Davila JA; Kramer JR; Durfee J; Kanwal F
    Dig Dis Sci; 2013 Nov; 58(11):3117-26. PubMed ID: 23868438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.